Sign In
Buy CLVS
$0.151
+0 (+0%)
At Close: Apr 19, 2023
Why Clovis Oncology Stock Went Into Retreat Mode This Week
09:53am, Friday, 15'th Jul 2022
After a massive surge in its share price recently, Clovis Oncology has started to reverse course.
Clovis Oncology: Managing A Winning Position After Recent Company Updates
09:15am, Wednesday, 13'th Jul 2022
Clovis Oncology has recently been on a winning streak of clinical data and corporate updates. As a result, the share price has rocketed off its 52-week lows. The company's theranostic FAP was able to
Clovis Oncology: Shares Pop And Drop Around FDA News (Technical Analysis)
12:39pm, Monday, 11'th Jul 2022
Biotech stocks are back in favor as some risk-on activity permeates the broader market. Clovis Oncology (CLVS) shares spiked from under 50 cents to above $3 recently as news about its key drugs stirs
Tesla, Twitter And 76 Biggest Movers From Friday
11:30am, Monday, 11'th Jul 2022 Benzinga
Gainers
Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board recomme
Dow Rises 75 Points; Kura Sushi USA Shares Spike Higher
06:42pm, Friday, 08'th Jul 2022 Benzinga
U.S. stocks traded slightly higher toward the end of trading as investors digested the recent jobs report for the month of June.
The Dow traded up 0.24% to 31,460 while the NASDAQ rose 0.28% to 11,65
Dow Turns Positive After Better-Than-Expected Jobs Report
04:34pm, Friday, 08'th Jul 2022 Benzinga
U.S. stocks turned higher midway through trading as investors digested the recent jobs report for the month of June.
The Dow traded up 0.21% to 31,450.12 while the NASDAQ rose 0.21% to 11,646.33. The
Tesla, WD-40 Company And 40 Stocks Moving In Friday's Mid-Day Session
04:20pm, Friday, 08'th Jul 2022 Benzinga
Gainers
Aditxt, Inc. (NASDAQ: ADTX) shares surged 75.7% to $0.2812 after the company's Adimune therapeutic program completed a toxicology study indicating a favorable safety profile of ADI-100.
Serit
Why Clovis Oncology Stock Is Crushing It Today
03:36pm, Friday, 08'th Jul 2022 The Motley Fool
Shareholders didn't give short-sellers what they wanted.
Is Clovis Oncology (CLVS) Stock the Next Big Squeeze?
02:44pm, Friday, 08'th Jul 2022
Clovis Oncology is skyrocketing after being flagged as a top gamma squeeze candidate. Here's why investors should be watching CLVS stock.
Why U.S. Stocks Are Trading Lower Despite Upbeat Nonfarm Payrolls Report
02:20pm, Friday, 08'th Jul 2022 Benzinga
U.S. stocks traded lower this morning following the release of jobs report for the month of June.
Following the market opening Friday, the Dow traded down 0.40% to 31,259.22 while the NASDAQ fell 0.92
Twitter And 20 Stocks Moving Premarket
10:33am, Friday, 08'th Jul 2022 Benzinga
Gainers
Seritage Growth Properties (NYSE: SRG) rose 35.7% to $8.25 in pre-market trading after gaining around 10% on Thursday. Seritage Growth Properties filed its preliminary proxy materials with th
Clovis Oncology (CLVS) Stock Gains as Shareholders Reject Reverse Stock Split
10:08am, Friday, 08'th Jul 2022
Clovis' (CLVS) shareholders decided to reject a proposal for a reverse split of CLVS stock. Clovis' shares appear to be rising on the news.
Why Clovis Oncology Shares Jumped 158.9% in June
08:33pm, Thursday, 07'th Jul 2022 The Motley Fool
The company might have vanquished delisting concerns with its surge.
Why Clovis Oncology Shares Jumped 158.9% in June
04:33pm, Thursday, 07'th Jul 2022
The company might have vanquished delisting concerns with its surge.
Why Clovis Oncology Stock Is Taking a Step Backward Today
04:27pm, Thursday, 07'th Jul 2022 The Motley Fool
A key label expansion for the company's ovarian cancer drug could take longer than expected.
